Advertisement

The Scientist

» drug safety

Most Recent

image: Epigenetic Cancer Therapy Clears Phase I

Epigenetic Cancer Therapy Clears Phase I

By | April 7, 2014

Investigational drug that inhibits proteins involved with epigenetic regulation shows activity against certain blood cancers in an early-stage clinical trial.

0 Comments

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

image: FDA Considers Easing Controls on Diabetes Drug

FDA Considers Easing Controls on Diabetes Drug

By | June 11, 2013

A panel of advisors says that the agency should loosen restrictions on the sale of a diabetes drug with a spotty clinical safety record.  

0 Comments

image: How Safe Is Your Medicine Cabinet?

How Safe Is Your Medicine Cabinet?

By | May 1, 2013

After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.

1 Comment

image: Opinion: Regenerating Safely

Opinion: Regenerating Safely

By | January 21, 2013

Patient safety is paramount in regulating new stem cell treatments.

1 Comment

image: Fears over Fast-Tracking Drugs

Fears over Fast-Tracking Drugs

By | September 10, 2012

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.

0 Comments

image: Call for Diabetes Drug Ban

Call for Diabetes Drug Ban

By | April 30, 2012

A consumer advocacy group calls for a ban of a diabetes drug after evidence surfaces that it may increase the risk of cancer.

0 Comments

image: FDA Ups Recent Recalls

FDA Ups Recent Recalls

By | November 9, 2011

The US regulatory agency recalled 54 percent more drugs from the second to third quarters of 2011.

3 Comments

image: Opinion: Sustainable Drug Monitoring

Opinion: Sustainable Drug Monitoring

By | August 31, 2011

Pharmacovigilance must keep pace with global distribution of drugs in resource-limited settings.

3 Comments

image: European Drug Agency Faces Scrutiny

European Drug Agency Faces Scrutiny

By | August 4, 2011

Europe’s anti-fraud office has launched an investigation into potential conflicts of interest at the EU’s drug approval agency.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Eppendorf
Eppendorf
Advertisement
NeuroScientistNews
NeuroScientistNews